Vita Coco (COCO) CCO logs 8,045-share Rule 10b5-1 stock sale

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 8,045 shares of common stock at $75.05 per share, executed under a Rule 10b5-1 trading plan. After this sale, he directly holds 59,085 common shares.

He also holds several non-qualified stock options to buy common stock, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates from 2030 to 2035, reflecting a continuing equity-based position in the company.

Insights

Equity compensation and insider-trading analyst

Routine 10b5-1 open-market sale with sizable remaining holdings.

Chief Commercial Officer Charles van Es sold 8,045 common shares of Vita Coco at $75.05 per share. A footnote states the sale was made under a Rule 10b5-1 trading plan, indicating it was pre-scheduled rather than a discretionary market-timing decision.

Following the sale, he still directly owns 59,085 common shares. In addition, he retains multiple non-qualified stock options with exercise prices between $10.178 and $33.36, expiring between 2030 and 2035. These unexercised options show continued equity exposure aligned with longer-term company performance.

The filing therefore reflects a planned liquidity event with substantial remaining ownership and option-based incentives, a pattern that is generally viewed as routine for senior executives.

Insider Trade Summary 10b5-1

Net Seller: 8,045 shares ($603,777)

Net Sell 9 txns

Insider van Es Charles

Role Chief Commercial Officer

Sold 8,045 shs ($604K)

Type	Security	Shares	Price	Value
Sale	Common Stock	8,045	$75.05	$604K
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 59,085 shares (Direct, null); Non-Qualified Stock Option (Right to Buy) — 53,750 shares (Direct, null)

Footnotes (1)

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock options vest in four annual equal installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

Key Figures

Shares sold: 8,045 shares Sale price per share: $75.05 per share Shares held after sale: 59,085 shares +3 more

6 metrics

Shares sold 8,045 shares Common stock sold in open-market transaction

Sale price per share $75.05 per share Price for 8,045 common shares sold

Shares held after sale 59,085 shares Direct common stock holdings post-transaction

Option exercise price $33.36 Non-qualified stock option exercise price, expiring 2035-03-04

Largest option block 58,043 underlying shares Non-qualified stock option at $15.00, expiring 2031-10-21

Performance-vested option 14,025 shares Vested on February 20, 2026 upon satisfying performance conditions

Key Terms

Rule 10b5-1 trading plan, Non-Qualified Stock Option (Right to Buy), performance conditions, vests in four equal annual installments, +1 more

5 terms

Rule 10b5-1 trading plan financial

"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Non-Qualified Stock Option (Right to Buy) financial

"security_title: Non-Qualified Stock Option (Right to Buy)"

performance conditions financial

"eligible to vest if certain performance conditions are met by the target date"

vests in four equal annual installments financial

"The stock option vests in four equal annual installments beginning on March 4, 2025."

expiration date financial

"expiration_date: 2035-03-04T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van Es Charles

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S(1)		8,045	D	$75.05	59,085	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	02/10/2030	Common Stock	53,750		53,750	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	01/11/2031	Common Stock	27,300		27,300	D
Non-Qualified Stock Option (Right to Buy)	$15							(3)	10/21/2031	Common Stock	58,043		58,043	D
Non-Qualified Stock Option (Right to Buy)	$15.36							(4)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(5)	03/10/2033	Common Stock	14,025		14,025	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(6)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(7)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (Right to Buy)	$33.36							(8)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option is fully vested and currently exercisable.

3. The stock option vests in four equal annual installments beginning on November 27, 2022.

4. The stock option vests in three equal annual installments beginning on August 15, 2025.

5. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.

6. The stock options vest in four annual equal installments beginning on March 10, 2024.

7. The stock option vests in four equal annual installments beginning on March 4, 2025.

8. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	/s/ Alison Klein, attorney-in-fact for Charles van Es	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vita Coco (COCO) report for Charles van Es?

Vita Coco reported that Chief Commercial Officer Charles van Es sold 8,045 shares of common stock. The shares were sold at $75.05 per share in an open-market transaction executed under a Rule 10b5-1 trading plan, indicating pre-arranged trading.

How many Vita Coco (COCO) shares does Charles van Es hold after this Form 4?

After the reported sale, Chief Commercial Officer Charles van Es directly holds 59,085 shares of Vita Coco common stock. This figure reflects his remaining direct ownership position following the open-market disposition of 8,045 shares disclosed in the Form 4 filing.

Was the Vita Coco (COCO) insider sale under a Rule 10b5-1 plan?

Yes. A footnote states the common stock sales were made pursuant to a Rule 10b5-1 trading plan. Such plans are pre-arranged schedules for trading, designed to allow insiders to sell shares over time without making discretionary timing decisions.

What stock options does Charles van Es hold in Vita Coco (COCO)?

Charles van Es holds several non-qualified stock options over Vita Coco common stock with exercise prices between $10.178 and $33.36. These options cover blocks such as 58,043, 42,980, and 27,300 underlying shares, with expirations from 2030 to 2035.

Are Charles van Es’s Vita Coco (COCO) stock options currently exercisable?

According to a footnote, at least one stock option is fully vested and currently exercisable. Other options vest in annual installments or upon meeting specified performance conditions, creating a schedule of potential future exercisability tied to service and performance milestones.

Do performance conditions affect any Vita Coco (COCO) options held by Charles van Es?

Yes. One option grant vests based on performance conditions. The filing notes these conditions were timely satisfied, leading to vesting of the option as to 14,025 shares on February 20, 2026, while unachieved conditions would have caused expiration.